Social Pulse: Achillion Pharmaceuticals Inc (ACHN.O)
ACHN.O on Nasdaq
7.56USD
10:03am EDT
7.56USD
10:03am EDT
Price Change (% chg)
$-0.18 (-2.33%)
$-0.18 (-2.33%)
Prev Close
$7.74
$7.74
Open
$7.66
$7.66
Day's High
$7.70
$7.70
Day's Low
$7.44
$7.44
Volume
235,056
235,056
Avg. Vol
1,115,341
1,115,341
52-wk High
$11.36
$11.36
52-wk Low
$5.42
$5.42
- Achillion Pharmaceuticals, Inc. Presents at UBS Global Healthcare Conference, May-21-2013 03:30 PM
- The Young And Restless Retirement Portfolio: Stay The Course
- Achillion: Down But Not Out And Progress Being Made
- Young And Restless Portfolio: BlackBerry Will Be The Catalyst
- Tough Day for This Hepatitis C Underdog
- Achillion: Moving Beyond Sofosbuvir's Shadow
Press Releases
- Achillion to Present at Two Upcoming Investor Conferences
- Achillion to Present at Two Upcoming Investor Conferences
- Direction Change Ahead, What to Expect - Research & Analysis on Achillion Pharmaceuticals, Inc. and Vertex Pharmaceuticals Incorporated
- Achillion Provides Update on Clinical HCV Development Programs
- Achillion Pharmaceuticals, Inc. Hosts the HCV Connection Media Briefing at the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
